Evidence Prime at BioTechX Europe 2025
Dates: 6–8 October 2025
Location: Messe Basel, Basel, Switzerland

AI Improving Research
Artur Nowak, co-founder and CTO at Evidence Prime, will be speaking at BioTechX Europe 2025. With over a decade of experience in building tools for evidence-based medicine, Artur focuses on applying AI to improve how organizations create, manage, and use scientific evidence. With the help of AI in research, individuals can accelerate discoveries, fast-track improvements in healthcare, and organize and interpret information more efficiently. AI helps by rapidly processing vast amounts of data, identifying patterns that might otherwise be overlooked, and generating insights that guide the formulation of new hypotheses. In literature-based research, AI tools streamline tasks such as screening, data extraction, and summarization, allowing researchers to focus on analysis and decision-making rather than repetitive manual work. By reducing time and effort, AI not only makes research more efficient but also enables up-to-date and comprehensive findings.
Sessions to attend
We will be participating in the following sessions at BioTechX Europe 2025:
- Are LLMs enough? — Panel discussion, Day 1 at 17:25. Exploring the practical limits and realistic uses of LLMs in scientific workflows.
- FAIR AI for Evidence Synthesis: A Human-in-the-Loop Workflow for Generating Interoperable Enterprise Knowledge — Presentation, Day 2 at 13:10. A deep dive into workflows that align LLM outputs with enterprise ontologies and stewarded governance processes.
Learn more
Evidence Prime develops AI-enabled software to improve research. Our tools include Laser AI, a tool for systematic reviews, and GRADEpro, a software that improves the guideline development process. To learn more about AI in research, risks, and benefits, read our blog about building trust in AI in research.
At BioTechX, we will share how our Laser AI platform supports secure, auditable, and FAIR-aligned evidence generation for life sciences and healthcare organizations.
